Subtotal: R2 300,00
HDL Retat 32
R2 100,00
Retatrutide is a medicine for weight loss and weight maintenance that contains the active substance Retatrutide.
Guarantee safe & secure checkout
On all order
Description
Retatrutide is a medicine for weight loss and weight maintenance that contains the active substance Retatrutide.
Additional information
| Colour | Emerald Green, Royal Blue, Burnt Orange, Turquoise Teal, Mustard Yellow |
|---|
Quick Comparison
| HDL Retat 32 remove | BP Tirze 30 remove | NOVA NAD+ remove | BP Retat 32 remove | BP Retat 64 remove | 8-in-1 Body Contouring & Slimming Treatment remove | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | HDL Retat 32 remove | BP Tirze 30 remove | NOVA NAD+ remove | BP Retat 32 remove | BP Retat 64 remove | 8-in-1 Body Contouring & Slimming Treatment remove | ||||||||||||
| Image | | | | | |  | ||||||||||||
| SKU | IN_LK-9 | IN_LK-6 | IN_LK-24 | IN_LK-3 | IN_LK-4 | |||||||||||||
| Rating | ||||||||||||||||||
| Price | R2 100,00 | R2 800,00 | R1 200,00 | R3 600,00 | R4 300,00 | R56,00 | ||||||||||||
| Stock | ||||||||||||||||||
| Weight | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||||
| Dimensions | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||||
| Additional information |
|
|
|
|
|
| ||||||||||||
| Description | Retatrutide is a medicine for weight loss and weight maintenance that contains the active substance Retatrutide. | BodyPharm (BP) Tirzepatide 30mg is a high-concentration research compound designed to mimic the action of hormones that manage blood sugar and appetite, primarily marketed in South Africa for laboratory use. [1, 2] | The NovaNAD+ 400mg Pen is a high-strength pharmaceutical-grade NAD+ injection system designed for advanced anti-aging and biohacking. |
|
| Advanced Non-Surgical Fat Reduction and Body Sculpting Our professional 8-in-1 slimming system combines multiple technologies to help reduce fat, tighten skin, smooth cellulite, | ||||||||||||
| Add to cart |
Reviews
There are no reviews yet.